CHRNA7 and Alzheimer disease: Initial imaging studies with the α7 nAChR selective radioligand [18F]ASEM in healthy controls and MCI subjects indicated elevation of this receptor subtype with healthy aging, and in MCI, in a direction opposite of that for α4β2 nAChR in AD (Coughlin et al., 2018, 2019).